Please use this identifier to cite or link to this item: https://doi.org/10.1097/JTO.0b013e3181913e28
Title: Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
Authors: Lim, E.H. 
Chang, A.
Tan, P. 
Zhang, S.-L. 
Li, J.-L.
Yap, W.-S.
Ng, A.
Howe, T.-C.
Tan, B.-P.
Lee, Y.-S.
Wong, D.
Khoo, K.-L.
Seto, K.-Y.
Tan, L. 
Agasthian, T.
Koong, H.-N. 
Tam, J. 
Tan, C.
Caleb, M. 
Keywords: Advanced stage
CMET mutations
Early stage
EGFR mutations
KRAS mutations
Low-volume biopsies
Non-small cell lung cancer
P53 mutations
Prognosis
Whole genome amplification
Issue Date: 2009
Source: Lim, E.H.,Chang, A.,Tan, P.,Zhang, S.-L.,Li, J.-L.,Yap, W.-S.,Ng, A.,Howe, T.-C.,Tan, B.-P.,Lee, Y.-S.,Wong, D.,Khoo, K.-L.,Seto, K.-Y.,Tan, L.,Agasthian, T.,Koong, H.-N.,Tam, J.,Tan, C.,Caleb, M. (2009). Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology 4 (1) : 12-21. ScholarBank@NUS Repository. https://doi.org/10.1097/JTO.0b013e3181913e28
Source Title: Journal of Thoracic Oncology
URI: http://scholarbank.nus.edu.sg/handle/10635/24184
ISSN: 15560864
15561380
DOI: 10.1097/JTO.0b013e3181913e28
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

48
checked on Dec 13, 2017

Page view(s)

167
checked on Dec 15, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.